Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Medtronic
Fish and Richardson
Citi
Boehringer Ingelheim
Chubb
Express Scripts
Covington

Generated: November 13, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for CT-011

« Back to Dashboard

US Patents for CT-011

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CT-011 ➤ Try a Free Trial Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor Amgen Inc. (Thousand Oaks, CA) ➤ Try a Free Trial
CT-011 ➤ Try a Free Trial Synergistic combination of immunologic inhibitors for the treatment of cancer The University of Chicago (Chicago, IL) ➤ Try a Free Trial
CT-011 ➤ Try a Free Trial Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapy CCAM BIOTHERAPEUTICS LTD. (Hod Hasharon, IL) ➤ Try a Free Trial
CT-011 ➤ Try a Free Trial Antibody molecules to TIM-3 and uses thereof Novartis AG (Basel, CH) DANA-FARBER CANCER INSTITUTE, INC. (Boston, MA) Children's Medical Center Corporation (Boston, MA) ➤ Try a Free Trial
CT-011 ➤ Try a Free Trial Disease therapy by inducing immune response to Trop-2 expressing cells IBC Pharmaceuticals, Inc. (Morris Plains, NJ) ➤ Try a Free Trial
CT-011 ➤ Try a Free Trial Disease therapy by inducing immune response to Trop-2 expressing cells IBC Pharmaceuticals, Inc. (Morris Plains, NJ) ➤ Try a Free Trial
CT-011 ➤ Try a Free Trial Combination of vaccination and inhibition of the PD-1 pathway CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for CT-011

Drugname Country Document Number Estimated Expiration Related US Patent
CT-011 Australia 2013308595 2032-08-30 ➤ Try a Free Trial
CT-011 Australia 2018208640 2032-08-30 ➤ Try a Free Trial
CT-011 Canada 2881851 2032-08-30 ➤ Try a Free Trial
CT-011 China 104704002 2032-08-30 ➤ Try a Free Trial
CT-011 Eurasian Patent Organization 201590451 2032-08-30 ➤ Try a Free Trial
CT-011 European Patent Office 2890714 2032-08-30 ➤ Try a Free Trial
CT-011 Hong Kong 1211601 2032-08-30 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Fuji
QuintilesIMS
Dow
Harvard Business School
Baxter
Cipla
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.